DAFNA Capital Management LLC - APPLIED GENETIC TECHNOL CORP ownership

APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 78 filers reported holding APPLIED GENETIC TECHNOL CORP in Q2 2017. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of APPLIED GENETIC TECHNOL CORP
ValueSharesWeighting
Q1 2021$2,181,000
-41.0%
430,111
-52.4%
0.52%
-53.0%
Q4 2020$3,695,000
-30.6%
903,429
-17.5%
1.10%
-36.5%
Q3 2020$5,322,000
-17.2%
1,095,139
-5.7%
1.73%
-6.8%
Q2 2020$6,431,000
+68.9%
1,160,8780.0%1.86%
+16.8%
Q1 2020$3,808,000
+134.5%
1,160,878
+223.2%
1.59%
+185.3%
Q4 2019$1,624,000
+8.7%
359,1900.0%0.56%
-0.9%
Q3 2019$1,494,000
+9.8%
359,1900.0%0.56%
+9.8%
Q2 2019$1,361,000
-9.6%
359,1900.0%0.51%
-21.1%
Q1 2019$1,505,000
+68.3%
359,1900.0%0.65%
+45.8%
Q4 2018$894,000
-66.0%
359,190
-0.2%
0.44%
-58.8%
Q3 2018$2,627,000
+68.6%
359,860
-14.5%
1.08%
+48.0%
Q2 2018$1,558,000
-3.9%
421,0000.0%0.73%
-7.6%
Q1 2018$1,621,000
+6.9%
421,0000.0%0.79%
-3.3%
Q4 2017$1,516,000
-8.8%
421,0000.0%0.82%
-21.0%
Q3 2017$1,663,000
-22.5%
421,0000.0%1.03%
-32.6%
Q2 2017$2,147,000
-24.3%
421,000
+2.4%
1.53%
-36.1%
Q1 2017$2,836,000
+5.9%
411,000
+43.6%
2.40%
+2.0%
Q4 2016$2,677,000
+13.9%
286,298
+19.1%
2.35%
+43.7%
Q3 2016$2,350,000
-0.5%
240,298
+43.7%
1.64%
-12.6%
Q2 2016$2,362,000
+1.1%
167,1920.0%1.87%
-7.1%
Q1 2016$2,337,000
-27.1%
167,192
+6.4%
2.02%
-29.5%
Q4 2015$3,207,000
+55.2%
157,1920.0%2.86%
+39.5%
Q3 2015$2,066,000
-14.3%
157,1920.0%2.05%
+0.5%
Q2 2015$2,411,000
+10.3%
157,192
+43.8%
2.04%
+21.5%
Q1 2015$2,185,000109,3231.68%
Other shareholders
APPLIED GENETIC TECHNOL CORP shareholders Q2 2017
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,455,904$7,075,0002.04%
DAFNA Capital Management LLC 1,095,139$5,322,0001.73%
Portolan Capital Management 1,301,075$6,323,0000.72%
Sofinnova Investments, Inc. 825,071$4,010,0000.30%
Ikarian Capital, LLC 545,884$2,654,0000.19%
683 Capital Management, LLC 364,299$1,770,0000.13%
Gyon Technologies Capital Management, LP 18,653$91,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 336,900$1,637,0000.07%
HighVista Strategies LLC 15,200$74,0000.05%
PURA VIDA INVESTMENTS, LLC 176,411$857,0000.04%
View complete list of APPLIED GENETIC TECHNOL CORP shareholders